AMY PRICE: Open Payments
NPI 1245537067 · OMAHA, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,438 in 110 payments from 22 companies in 2025. Trend: 2023 $2,215 · 2024 $2,488 · 2025 $2,438
Food & beverage: $2,338Education: $100
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 10 | $291 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 13 | $281 |
| Regeneron Healthcare Solutions, Inc. | 8 | $276 |
| Lilly USA, LLC | 12 | $235 |
| ABBVIE INC. | 12 | $204 |
| ConvaTec Inc. | 9 | $197 |
| Novartis Pharmaceuticals Corporation | 7 | $177 |
| LEO Pharma Inc. | 5 | $114 |
| Janssen Biotech, Inc. | 6 | $113 |
| UCB, Inc. | 4 | $90 |
Products named: DUPIXENT, TALTZ, INNOVAMATRIX AC, SKYRIZI, ILUMYA, COSENTYX, TREMFYA, Bimzelx.
Industry payments across NE — which companies pay providers there.
